Retsef Levi, PhD, who teaches operations management and healthcare decision-making at MIT and is not a physician, was ...

Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention ...

“FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” said Andrew Nixon, spokesperson for the U.S. Department of Health and Human ...

The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...

Findings from a phase 3 study provided additional evidence that the first pneumococcal vaccine made specifically for adults ...

If the FDA ceases to be a predictable source of regulatory guidance, then China will gain a significant advantage in the race ...

Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up.

You hear about the flu vaccine, the COVID-19 vaccine, even the pneumonia vaccine, but in 2023, the FDA approved the first RSV ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...

And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...

The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by CNN. It ...